https://www.stocktitan.net/overview/PPCB/
PPCB Stock Price, News & Analysis | Propanc Bio
May 15, 2026 - Propanc Biopharma (PPCB) is a Nasdaq-listed biopharmaceutical company developing proenzyme-based therapies for recurrent and metastatic cancer.
stock price newsppcbanalysisbio